135 related articles for article (PubMed ID: 22105616)
1. Is the C34T polymorphism of the AMPD1 gene associated with athlete performance in rowing?
Ciȩszczyk P; Eider J; Ostanek M; Leońska-Duniec A; Ficek K; Kotarska K; Girdauskas G
Int J Sports Med; 2011 Dec; 32(12):987-91. PubMed ID: 22105616
[TBL] [Abstract][Full Text] [Related]
2. Ecto- and cytosolic 5'-nucleotidases in normal and AMP deaminase-deficient human skeletal muscle.
Hanisch F; Hellsten Y; Zierz S
Biol Chem; 2006 Jan; 387(1):53-8. PubMed ID: 16497164
[TBL] [Abstract][Full Text] [Related]
3. AMPD1 rs17602729 is associated with physical performance of sprint and power in elite Lithuanian athletes.
Ginevičienė V; Jakaitienė A; Pranculis A; Milašius K; Tubelis L; Utkus A
BMC Genet; 2014 May; 15():58. PubMed ID: 24885427
[TBL] [Abstract][Full Text] [Related]
4. Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family Study.
Rico-Sanz J; Rankinen T; Joanisse DR; Leon AS; Skinner JS; Wilmore JH; Rao DC; Bouchard C;
Physiol Genomics; 2003 Jul; 14(2):161-6. PubMed ID: 12783984
[TBL] [Abstract][Full Text] [Related]
5. World-class performance in lightweight rowing: is it genetically influenced? A comparison with cyclists, runners and non-athletes.
Muniesa CA; González-Freire M; Santiago C; Lao JI; Buxens A; Rubio JC; Martín MA; Arenas J; Gomez-Gallego F; Lucia A
Br J Sports Med; 2010 Sep; 44(12):898-901. PubMed ID: 18801770
[TBL] [Abstract][Full Text] [Related]
6. Genotype distributions in top-level soccer players: a role for ACE?
Juffer P; Furrer R; González-Freire M; Santiago C; Verde Z; Serratosa L; Morate FJ; Rubio JC; Martin MA; Ruiz JR; Arenas J; Gómez-Gallego F; Lucia A
Int J Sports Med; 2009 May; 30(5):387-92. PubMed ID: 19277943
[TBL] [Abstract][Full Text] [Related]
7. The angiotensin converting enzyme gene I/D polymorphism in Polish rowers.
Cieszczyk P; Krupecki K; Maciejewska A; Sawczuk M
Int J Sports Med; 2009 Aug; 30(8):624-7. PubMed ID: 19455482
[TBL] [Abstract][Full Text] [Related]
8. Distribution of the AMPD1 C34T polymorphism in Polish power-oriented athletes.
Cieszczyk P; Ostanek M; Leońska-Duniec A; Sawczuk M; Maciejewska A; Eider J; Ficek K; Sygit K; Kotarska K
J Sports Sci; 2012; 30(1):31-5. PubMed ID: 22017426
[TBL] [Abstract][Full Text] [Related]
9. AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization.
Andreassi MG; Botto N; Laghi-Pasini F; Manfredi S; Ghelarducci B; Farneti A; Solinas M; Biagini A; Picano E
Int J Cardiol; 2005 May; 101(2):191-5. PubMed ID: 15882662
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients.
Collins RP; Palmer BR; Pilbrow AP; Frampton CM; Troughton RW; Yandle TG; Skelton L; Richards AM; Cameron VA
Am Heart J; 2006 Aug; 152(2):312-20. PubMed ID: 16875916
[TBL] [Abstract][Full Text] [Related]
11. Effect of AMPD1 gene polymorphism on muscle activity in humans.
Fedotovskaya ON; Danilova AA; Akhmetov II
Bull Exp Biol Med; 2013 Feb; 154(4):489-91. PubMed ID: 23486588
[TBL] [Abstract][Full Text] [Related]
12. Effect of adenosine monophosphate deaminase-1 C34T allele on the requirement for donor inotropic support and on the incidence of early graft dysfunction after cardiac transplantation.
Taegtmeyer AB; Breen JB; Rogers P; Johnson PH; Smith J; Smolenski RT; Banner NR; Yacoub MH; Barton PJ
Am J Cardiol; 2009 May; 103(10):1457-62. PubMed ID: 19427446
[TBL] [Abstract][Full Text] [Related]
13. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients.
de Groote P; Lamblin N; Helbecque N; Mouquet F; Hermant X; Amouyel P; Dallongeville J; Bauters C
Am Heart J; 2006 Oct; 152(4):736-41. PubMed ID: 16996850
[TBL] [Abstract][Full Text] [Related]
14. AMPD1 C34T mutation selectively affects AMP-deaminase activity in the human heart.
Kalsi KK; Yuen AH; Johnson PH; Birks EJ; Yacoub MH; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2005; 24(4):287-8. PubMed ID: 16021918
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms influencing muscle phenotypes in North-African and Spanish populations.
Fernández-Santander A; Valveny N; Harich N; Kandil M; Luna F; Martín MÁ; Rubio JC; Lucia A; Gaibar M
Ann Hum Biol; 2012 Mar; 39(2):166-9. PubMed ID: 22324844
[TBL] [Abstract][Full Text] [Related]
16. The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure.
Kolek MJ; Carlquist JF; Thaneemit-Chen S; Lazzeroni LC; Whiting BM; Horne BD; Muhlestein JB; Lavori P; Anderson JL
J Card Fail; 2005 Dec; 11(9):677-83. PubMed ID: 16360962
[TBL] [Abstract][Full Text] [Related]
17. AMPD1 gene polymorphism and the vasodilatory response to ischemia.
Hand BD; Roth SM; Roltsch MH; Park JJ; Kostek MC; Ferrell RE; Brown MD
Life Sci; 2006 Sep; 79(15):1413-8. PubMed ID: 16707139
[TBL] [Abstract][Full Text] [Related]
18. Frequency of the C34T mutation of the AMPD1 gene in world-class endurance athletes: does this mutation impair performance?
Rubio JC; Martín MA; Rabadán M; Gómez-Gallego F; San Juan AF; Alonso JM; Chicharro JL; Pérez M; Arenas J; Lucia A
J Appl Physiol (1985); 2005 Jun; 98(6):2108-12. PubMed ID: 15677729
[TBL] [Abstract][Full Text] [Related]
19. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
Gastmann A; Sigusch HH; Henke A; Reinhardt D; Surber R; Gastmann O; Figulla HR
Am J Cardiol; 2004 May; 93(10):1260-4. PubMed ID: 15135700
[TBL] [Abstract][Full Text] [Related]
20. Trp64Arg polymorphism in ADRB3 gene is associated with elite endurance performance.
Santiago C; Ruiz JR; Buxens A; Artieda M; Arteta D; González-Freire M; Rodríguez-Romo G; Altmäe S; Lao JI; Gómez-Gallego F; Lucia A
Br J Sports Med; 2011 Feb; 45(2):147-9. PubMed ID: 19553224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
